Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Matrixx Investment In Novel Oral Care Product Drags Down Q2 Income

This article was originally published in The Tan Sheet

Executive Summary

Matrixx Initiatives' second-quarter profits were impacted by higher R&D expenditure on a new oral care product that offers a "very unique delivery system," the firm announced during an earnings call July 25
Advertisement

Related Content

Late cold season impacts sales
Late cold season impacts sales
Late cold season impacts sales

Topics

Advertisement
UsernamePublicRestriction

Register

PS099610

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel